CorMedix (CRMD)

• Market cap: $576M
• 1 day: 3.39%
• 5 days: 1.95%
• 1 month: -5.8%
• 3 months: -22.23%
• 6 months: -46.76%
• Year to date: -39.88%
• 1 year: -28.96%
• 5 years: -53.68%
• 10 years: -18.32%
• Sector: Healthcare
• Industry: Biotechnology

About: Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Employees: 82